BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33842342)

  • 1. Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
    Wang G; Liu X; Wang D; Sun M; Yang Q
    Front Oncol; 2021; 11():636565. PubMed ID: 33842342
    [No Abstract]   [Full Text] [Related]  

  • 2. TCGAnalyzeR: An Online Pan-Cancer Tool for Integrative Visualization of Molecular and Clinical Data of Cancer Patients for Cohort and Associated Gene Discovery.
    Zengin T; Masud BA; Önal-Süzek T
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma.
    Bai Y; Lin H; Chen J; Wu Y; Yu S
    Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985
    [No Abstract]   [Full Text] [Related]  

  • 4. A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer.
    Ye Y; Dai Q; Li S; He J; Qi H
    Front Mol Biosci; 2021; 8():645845. PubMed ID: 33869286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of ferroptosis-related genes in patients with lung adenocarcinoma.
    Zhu G; Huang H; Xu S; Shi R; Gao Z; Lei X; Zhu S; Zhou N; Zu L; Mello RA; Chen J; Xu S
    Thorac Cancer; 2021 Jun; 12(12):1890-1899. PubMed ID: 33979897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis-related gene signature predicts prognosis and immunotherapy in glioma.
    Wan RJ; Peng W; Xia QX; Zhou HH; Mao XY
    CNS Neurosci Ther; 2021 Aug; 27(8):973-986. PubMed ID: 33969928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ferroptosis in breast cancer patients: a comprehensive analysis.
    Wu ZH; Tang Y; Yu H; Li HD
    Cell Death Discov; 2021 May; 7(1):93. PubMed ID: 33947836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma.
    Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y
    Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis.
    Guo H; Wang S; Ju M; Yan P; Sun W; Li Z; Wu S; Lin R; Xian S; Yang D; Wang J; Huang Z
    Front Cell Dev Biol; 2021; 9():642724. PubMed ID: 33842467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
    Zhang LH; Li LQ; Zhan YH; Zhu ZW; Zhang XP
    Front Mol Biosci; 2021; 8():607090. PubMed ID: 33937319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.
    Wu F; Liu YW; Li GZ; Zhai Y; Feng YM; Ma WP; Zhao Z; Zhang W
    Br J Cancer; 2021 Jul; 125(2):255-264. PubMed ID: 34006924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.
    Chang K; Yuan C; Liu X
    Front Oncol; 2021; 11():649347. PubMed ID: 33996565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Tumor Microenvironment-Related Alternative Splicing Events to Predict the Prognosis of Endometrial Cancer.
    Liu X; Liu C; Liu J; Song Y; Wang S; Wu M; Yu S; Cai L
    Front Oncol; 2021; 11():645912. PubMed ID: 33996564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: A promise towards disease remission.
    Tyagi K; Mandal S; Roy A
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188563. PubMed ID: 33971276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ProTICS reveals prognostic impact of tumor infiltrating immune cells in different molecular subtypes.
    Liu S; Zhang Y; Shang X; Zhang Z
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33963834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma.
    Xu Z; Xu L; Liu L; Li H; Jin J; Peng M; Huang Y; Xiao H; Li Y; Guan H
    Front Oncol; 2021; 11():625452. PubMed ID: 33954109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma.
    Zhang N; Ge M; Jiang T; Peng X; Sun H; Qi X; Zou Z; Li D
    Front Oncol; 2021; 11():592211. PubMed ID: 33928021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Panel of Five-lncRNA Signature as a Potential Biomarker for Predicting Survival in Gastric and Thoracic Cancers.
    Shao J; Lyu W; Zhou J; Xu W; Wang D; Liang S; Zhao J; Qin Y
    Front Genet; 2021; 12():666155. PubMed ID: 33927753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.